Granules India receives an accreditation certificate from Japan, Brazilian drug regulators

A pharmaceutical company, Granules India, announced gaining an accreditation certificate from the Pharmaceuticals and Medical Devices Agency (PMDA), a Japanese organization, and compliance approval from ANVISA, the Brazilian health regulator.

 

The company's Jeedimetla plant in Telangana received the accreditation certificate, which is necessary for international pharmaceutical companies to sell medicines to Japan.

 

“The certification has been received for accreditation categories of non-sterile drugs, packaging, labeling, and storage of drugs,” the company said.

 

For its Bonthapally facility in Telangana, the company gained approval from the Brazilian regulator for complying with good manufacturing practices guidelines. Active pharmaceutical ingredients (APIs) are produced by a facility.

 

Pharmaceutical raw materials are produced by Granules India. The company specializes in finished dosages, pharmaceutical formulation intermediates, and active pharmaceutical components.

 

Source: Media Reports

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Candlestick Patterns

blog-logo

11 mins read . 03 Oct 2024

Ascending Triangle Pattern - Definition, Tips, Component & How to Trade

  • 0 people read
blog-logo

IPO

blog-logo

5 mins read . 19 Sep 2024

Vision Infra Equipment Solutions Limited IPO

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions